Omega Fund III, L.P.

CIK 1403748 · last filed 2016-06-29

Omega Fund III, L.P. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing shows the insider bought $12.0M of PRTK on Jun 29, 2016. Across all open-market trades the lifetime net is +$12.0M, making them a net buyer over the disclosed history. The firm reports its address in St. Peter Port, Guernsey, X0. 2 SEC filings were submitted jointly with Omega Fund IV, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$12.00M

Filer Profile

Reported Address

PO BOX 431, 13-15 VICTORIA ROAD
CHANNEL ISLANDS
ST. PETER PORT, GUERNSEY, X0 GY1 3ZD

Phone

4401481713843

State of Incorporation

Cayman Islands

Related Filers

Omega Fund IV, L.P. — 2 joint filings, latest 2016-06-29

Otello Stampacchia — 2 joint filings, latest 2014-11-10

Omega Fund IV G.P. Manager, Ltd. — 1 joint filings, latest 2014-11-10

Omega Fund IV GP, L.P. — 1 joint filings, latest 2014-11-10

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Paratek Pharmaceuticals, Inc. (PRTK) Delisted	10%+ Owner	779,802	$2.23	$1.74M	$12.00M	1	2016-06-29

Recent Filings

1 filing

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-06-29	Paratek Pharmaceuticals, Inc. (PRTK) Delisted	Buy (P)	+923,076	$12.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.